ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,648.40
      1.01%
      US Tech 100
      19,050.40
      1.19%
      Dow Jones
      41,563.08
      0.55%
      Brent Oil
      76.995
      0.00%
      Bitcoin
      58,934.38
      -0.30%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Clearmind Medicine Inc (CMND)

      7. Clearmind Medicine Inc (CMND) News

      Clearmind Medicine Inc

      Clearmind Medicine Inc (CMND)

      Clearmind Medicine Inc
      1.31
      -0.01
      (-0.76%)
      Closed August 31 4:00PM
      Delayed by 15 minutes
      1.32
      0.01
      (0.76%)
      After Hours: 5:44PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      CMND News

      Official News Only

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
      Edgar (US Regulatory)
      June 13 2024
      CMND (-0.76%)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
      Edgar (US Regulatory)
      June 13 2024
      CMND (-0.76%)

      CMND Discussion

      View Posts
      Penny chatter Penny chatter 1 week ago
      Market cap 4.4 million is insane
      👍️0
      Penny chatter Penny chatter 1 week ago
      Big market patented product.
      👍️0
      subslover subslover 1 week ago
      Thank you, Penny. I wonder if this can work.
      👍️0
      Penny chatter Penny chatter 1 week ago
      Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment

      Source: GlobeNewswire Inc.?


      Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that it has received a new patent approval from the United States Patent and Trademark Office, marking another significant advancement in its proprietary MEAI-based binge behavior regulator program.

      The approved patent claims cover, among other things, a method of regulating the consumption of alcoholic beverages and a method of controlling binge behavior through the administration of an amine aminoindane, including 5-methoxy-2-aminoindan (MEAI), the Company's innovative psychedelic molecule. This latest patent further bolsters Clearmind’s extensive intellectual property portfolio in the psychedelic sector, which now includes 29 granted patents across 19 patent families, with protections secured in key jurisdictions such as the U.S., Europe, China, and India.

      Dr. Adi Zuloff-Shani, CEO of Clearmind, commented, “We are proud to continue leading the way in IP protection within this space. Expanding and maintaining our patent portfolio, particularly in the U.S., remains a key objective for us. We believe that we hold one of the largest portfolios in the market, covering our core areas: MEAI, binge behavior, addictions, mental disorders, as well as new psychedelic compounds and combinations identified and researched by our team.”

      MEAI is a novel psychoactive molecule that reduces the desire to consume alcoholic beverages while providing a mild euphoric, alcohol-like experience. It holds the potential to transform the lives of millions who struggle with moderating their alcohol intake. Clearmind’s MEAI-based flagship treatment targets Alcohol Use Disorder (AUD) and weight loss. AUD is a widespread condition that ranges from mild to severe and is characterized by an individual’s inability to control their alcohol consumption despite adverse social, occupational, or health consequences. Clearmind’s MEAI may also be effective in treating binge drinking, a potentially life-threatening addiction.

      👍️0
      subslover subslover 2 weeks ago
      Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders
      Vancouver, Canada, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the submission of a patent application under the international Patent Cooperation Treaty (“PCT”) as part of the company’s ongoing collaboration with the with Yissum Research Development Company of the Hebrew University of Jerusalem (“Yissum”) pursuant to the exclusive licensing agreement that the Company entered into with Yissum.

      This patent application refers to generation 3.0 of psychedelic compounds, methods of their preparation and uses thereof in the treatment of mental disorders and was developed by Prof. Dmitry Tsvelikhovsky of the Hebrew University of Jerusalem.

      The PCT submission will allow the company to proceed to the national phase, which involves submitting applications to regional offices in various countries to seek patent protection in major jurisdictions like the US, Europe, China and India.

      Dr. Adi Zuloff-Shani, CEO of Clearmind, commented, "Under the exclusive global license agreement we signed with Yissum, this patent submission, if approved, will secure the intellectual property rights of this important patent for the company. We strongly believe in the potential of psychedelic treatments to become a vital tool in treating, mental disorders and we see Clearmind, as a leading company in the space, continuing to drive innovation. We believe that this next generation psychedelic, featuring new and advanced molecules may offer an excellent therapeutic option to improve quality of life for patients suffering from mental disorders.”
      👍️0
      glenn1919 glenn1919 2 weeks ago
      CMND.......................................https://stockcharts.com/h-sc/ui?s=CMND&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 2 months ago
      CMND...........................................https://stockcharts.com/h-sc/ui?s=CMND&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 2 months ago
      CMND...................................https://stockcharts.com/h-sc/ui?s=CMND&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 2 months ago
      CMND 10Q expected Friday 6/28
      👍️0
      glenn1919 glenn1919 2 months ago
      CMND.....................................https://stockcharts.com/h-sc/ui?s=CMND&p=W&b=5&g=0&id=p86431144783
      👍️0
      tw0122 tw0122 2 months ago
      Clearmind Medicine Secured Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD Treatment
      👍️0
      Awl416 Awl416 4 months ago
      Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment
      👍️0
      Monksdream Monksdream 5 months ago
      And down it goes
      👍️0
      Monksdream Monksdream 5 months ago
      CMND under $2
      👍️0
      Nealio Nealio 5 months ago
      How many shares are outstanding for CMND? Thanks.
      👍️0
      Awl416 Awl416 5 months ago
      Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China
      👍️0
      Monksdream Monksdream 5 months ago
      CMND 10Q due 3/22
      👍️0
      Monksdream Monksdream 6 months ago
      CMND 10Q due 3/15
      👍️0
      Awl416 Awl416 6 months ago
      Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
      👍️0
      Awl416 Awl416 6 months ago
      Now now
      👍️0
      TIMGZ TIMGZ 7 months ago
      REENA, HOPE U ARE DOING WELLL, ****SO MANY FISHES TO FRY****WAY TO GO***

      HAPPY TRADING
      👍️0
      reena969 reena969 7 months ago
      CMND..hmmm....delay in market response to the news regarding CMND,Traders have been occupied this morning due to CHEA, YTEN, and FDMT.(Traded all three for nice profits)
      https://finance.yahoo.com/news/clearmind-medicine-receives-patent-approval-125100357.html
      👍️0
      reena969 reena969 7 months ago
      Not yet still adding
      Need those cheapie
      👍️0
      Bud-Wiser Bud-Wiser 7 months ago
      Here WEEEEE GO a baby -BOOM
      👍️0
      Bud-Wiser Bud-Wiser 7 months ago
      I’m loaded … I think this will be a solid week here
      👍️0
      TimeFades TimeFades 7 months ago
      Time to load
      👍️0
      TimeFades TimeFades 7 months ago
      Looks appetizing
      👍️0
      Monksdream Monksdream 7 months ago
      CMND new 52 week low
      👍️0
      Monksdream Monksdream 7 months ago
      CMND new 52 week low
      👍️0
      Monksdream Monksdream 8 months ago
      CMND new 52 week low
      👍️0
      TheFinalCD TheFinalCD 8 months ago
      $CMND Clearmind Medicine Inc. Announces Pricing of $2.4 Million Registered Direct and Private Placement
      https://newsfilter.io/articles/clearmind-medicine-inc-announces-pricing-of-24-million-registered-direct-and-private-placement-8bef08328438d3cb53724b7c9348a9a7
      👍️0
      Invest-in-America Invest-in-America 8 months ago
      CMND: News about 'Psychiatric Mushrooms' to fix crazy drunks.
      https://www.marketscreener.com/quote/stock/CLEARMIND-MEDICINE-INC-43371362/news/Clearmind-Medicine-Completed-Type-A-Meeting-with-the-FDA-45713831/
      👍️0
      Monksdream Monksdream 8 months ago
      CMND new 52 week low
      👍️0
      Awl416 Awl416 9 months ago
      Clearmind Medicine Achieved Positive Results in Cocaine Addiction Treatment

      I shouldn’t laugh especially with todays coke but I got a chuckle out of this
      👍️0
      weedtrader420 weedtrader420 9 months ago
      NEWS OUT
      👍️0
      Awl416 Awl416 9 months ago
      There she goes again
      👍️0
      weedtrader420 weedtrader420 9 months ago
      CMND💫 WOOHOOOOOO
      👍️0
      Nealio Nealio 9 months ago
      Sold at 7.87 for about a double, late last night's session. Best to you...careful of possible dilution now that the RS has been done. I bought for a swing, and was playing the bottom chart before the RS, and the news event people said was coming.
      👍️0
      Awl416 Awl416 9 months ago
      Watching mm ARCX is quite entertaining
      👍️0
      Nealio Nealio 9 months ago
      Swing trading...my scanner says float at 600k now; could move here and quickly
      👍️0
      Awl416 Awl416 9 months ago
      Knock knock who’s there?
      👍️0
      Disquisition Disquisition 9 months ago
      HORRIFIC DUMPING
      👍️0
      81vette 81vette 10 months ago
      50 to 1 reverse split,horrible news
      👍️0
      knrorrel knrorrel 10 months ago
      that's Very interesting and sounds very seductive.:

      that
      7.5 million share offering closed at 0.30, we trade less than 50% of the asking price

      imo


      👍️0
      knrorrel knrorrel 10 months ago
      $CMMD 6 months ago it was $5 , BOUNCE time
      https://www.stockscores.com/charts/charts/?ticker=cmnd

      👍️0
      knrorrel knrorrel 10 months ago
      Expect good news. ?
      👍️0
      81vette 81vette 10 months ago
      If real good news comes,watching for it
      👍️0
      TheFinalCD TheFinalCD 10 months ago
      30 repeat? https://ih.advfn.com/stock-market/NASDAQ/clearmind-medicine-CMND/historical
      Oct 11 2023 0.2263 0.0738 48.39% 0.157 0.345 0.155 63,363,303
      👍️0
      81vette 81vette 10 months ago
      Getting attention now,thanks for letting me know bro!!
      👍️0
      TheFinalCD TheFinalCD 10 months ago
      Clearmind Medicine Closes US$2.25 Million Public Offering
      https://finance.yahoo.com/news/clearmind-medicine-closes-us-2-161600535.html

      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173179438

      Message in reply to:
      $CMND .14 couple reasons why I like it:
      7.5m share Offering @ .30 closed, we are trading less than 50% of offering price
      They submitted an IND to the FDA on March 16, 2023 they are overdue to hear back from FDA, any positive news and this goes
      On 10/26 there was a SC13G filed for 7.7% or 1.2m shares
      At or near bottom, low risk imo, watching for breakout over .15 with sustained vol.
      👍️0

      Your Recent History

      NASDAQ
      CMND
      Clearmind Medicine
      USOTC
      CHSYF
      China Medical System (PK)
      USOTC
      CVVRF
      Vertical Exploration (PK)
      NASDAQ
      VRAR
      Glimpse
      Delayed Upgrade Clock